For physicians

What changes for the patient

The only argument for adding a diagnostic is that it changes what happens next. Here is where it does, and where it does not.

Five places management actually changes

1. A foot at risk gets identified before it ulcerates

The combination that produces a diabetic foot ulcer is loss of protective sensation plus impaired perfusion plus loss of sweating. Each is measurable, and the combination is far more predictive than any of them alone. A patient with absent sudomotor response, a reduced toe-brachial index and dry cracked skin is a referral to podiatry and a footwear conversation today, not after the first wound.

2. Burning feet with a normal nerve study stop being a dead end

This is the single most common clinical situation these assessments resolve. The patient has been told the nerve study is normal and has drawn the reasonable conclusion that nobody believes them. A small-fiber measurement either confirms the abnormality or genuinely excludes it, and both outcomes move the consultation forward.

3. Orthostatic symptoms get attributed correctly

Lightheadedness on standing is treated as dehydration, as a medication side effect, as anxiety or as inner-ear disease depending on who sees it. Autonomic measurement plus positional blood pressure separates these, and the treatments diverge sharply.

4. Fall risk becomes objective

“Have you fallen in the past year?” is the standard screening question and it depends entirely on recall and on willingness to admit it. Vestibular and oculomotor measurement plus sensory and autonomic data produces an assessment that does not.

5. Lifestyle advice acquires a feedback loop

The reason dietary and activity counseling so often fails is that neither party can see whether it worked for months. Measured metabolic rate, body composition, waist circumference and vascular indices can all be repeated, and a patient who can see a number move behaves differently from one who cannot.

Where it does not change anything

Honesty about this protects the rest of the argument.

• In a low-risk asymptomatic adult under 50, the yield is low and the testing is not indicated.
• In established, structurally advanced arterial disease, measurement documents what is already clinically evident and rarely changes the plan.
• In a patient who will not or cannot act on the result, an abnormal measurement adds anxiety and nothing else.
• None of these assessments replaces imaging, nerve conduction studies, echocardiography or specialist referral where those are indicated.

A note on how to present a result

These measurements are quantitative and easy to over-read. A borderline index or a single low heart-rate-variability reading is a reason to repeat under controlled conditions, not to start a treatment. The clinical value of the suite comes from the pattern and from the trend.

For patients: the same subject written for the person having the assessment is at understanding your results.

Common questions

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed August 20, 2026.